Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityTimes Interest Earned

Incannex Healthcare (IXHL) EBITDA Margin: 2024-2025

  • Incannex Healthcare's EBITDA Margin fell 11710811.00% to -124,000.00% in Q3 2025 from the same period last year, while for Sep 2025 it was 116,631.71%, marking a year-over-year change of. This contributed to the annual value of -54,302.33% for FY2025, which is 10016434.00% up from last year.
  • Incannex Healthcare's EBITDA Margin amounted to -124,000.00% in Q3 2025, which was down 4,135.50% from 3,072.73% recorded in Q1 2025.
  • In the past 5 years, Incannex Healthcare's EBITDA Margin ranged from a high of 3,072.73% in Q1 2025 and a low of -124,000.00% during Q3 2025.
  • Over the past 2 years, Incannex Healthcare's median EBITDA Margin value was -29,729.28% (recorded in 2024), while the average stood at -45,096.46%.
  • Data for Incannex Healthcare's EBITDA Margin shows a maximum YoY plummeted of 11,710,811bps (in 2025) over the last 5 years.
  • Incannex Healthcare's EBITDA Margin (Quarterly) stood at -52,566.67% in 2024, then slumped by 11,710,811bps to -124,000.00% in 2025.
  • Its EBITDA Margin was -124,000.00% in Q3 2025, compared to 3,072.73% in Q1 2025 and -52,566.67% in Q4 2024.